Characterization of the Cardiac Reinnervation of Patients With Transposition of the Great Arteries Long After Repair With the Arterial Switch Operation. Correlation With Electrocardiographic and Exercise Test Parameters

Sponsor
Hospital Universitari Vall d'Hebron Research Institute (Other)
Overall Status
Completed
CT.gov ID
NCT03469843
Collaborator
(none)
25
1
16.4
1.5

Study Details

Study Description

Brief Summary

Cardiac denervation is inherent to the arterial switch (ASO) technique for the repair of transposition of the great arteries (TGA) and the long term reinnervation process has not been studied. We sought to describe the reinnervation status of adult patients long after the ASO, to identify areas of myocardial perfusion/innervation mismatch and to assess the relation of innervation status and exercise capacity.

Condition or Disease Intervention/Treatment Phase
  • Other: Non intervention

Detailed Description

Cardiac denervation is inherent to the arterial switch (ASO) technique for the repair of transposition of the great arteries (TGA) and the long term reinnervation process has not been studied. We sought to describe the reinnervation status of adult patients long after the ASO, to identify areas of myocardial perfusion/innervation mismatch and to assess the relation of innervation status and exercise capacity.

Study Design

Study Type:
Observational
Actual Enrollment :
25 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Characterization of the Cardiac Reinnervation of Patients With Transposition of the Great Arteries Long After Repair With the Arterial Switch Operation. Correlation With Electrocardiographic and Exercise Test Parameters
Actual Study Start Date :
Apr 19, 2018
Actual Primary Completion Date :
Mar 1, 2019
Actual Study Completion Date :
Sep 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Patients

patients with transposition of the great arteries long after repair with the arterial switch operation

Other: Non intervention
patients without intervention
Other Names:
  • patients without intervention
  • Outcome Measures

    Primary Outcome Measures

    1. Myocardial innervation pattern on 123I-mlBG SPECT. [1 day]

      To describe the myocardial reinnervation pattern of a cohort of patients with TGA long after ASO using cardiac nuclear imaging.

    Secondary Outcome Measures

    1. Myocardial perfusion defects on cardiac nuclear imaging. [1 day]

      To identify myocardial perfusion defects using cardiac nuclear imaging.

    2. Myocardial innervation perfusion mismatch defects on cardiac nuclear imaging. [1 day]

      To identify myocardial innervations/perfusion mismatch using cardiac nuclear imaging.

    3. Treadmill exercise test. [1 day]

      To determine exercise capacity (METs and double product) and chronotropic response (Maximal heart rate and heart rate increase pattern). Correlate with myocardial reinnervation pattern and sinus node reinnervation. To determine exercise induced ischeamic ST segment changes. Correlate with myocardial perfusion defects and innervation-perfusion mismatch.

    4. 24 hours ECG Holter monitoring . [1 day]

      To determine sinus node innervation through heart rate variability (HRV) which will be assessed by time domain variables (the standard deviation of normal RR intervals (SDNN) and the square root of the mean of the squared differences between adjacent normal RR intervals (r-MSSD)) and frequency domain variables (variance of all R-R intervals - total power (TP); power in the very low frequency range - very low frequency (VLF, 0.003-0.04 Hz); power in the low frequency range-low frequency (LF, 0.04-0.15Hz); low frequency power in normalized units-normalized low frequency; power in the high frequency range-high frequency (HF, 0.15-0.40 Hz); and high frequency power in normalized units-normalized high frequency and the ratio of low frequency to high frequency (LF/HF)).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients with transposition of the great arteries repaired with the arterial switch.

    • Patients aged of more than 18 years-old.

    Exclusion Criteria:
    • Pregnancy or breast-feeding.

    • Denial of informed consent.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hospital Universitari Vall d'Hebron Barcelona Spain 08035

    Sponsors and Collaborators

    • Hospital Universitari Vall d'Hebron Research Institute

    Investigators

    • Principal Investigator: Laura Dos Subirà, PhD MD, Hospital Universitari Vall d'hebron Barcelona, Spain

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Hospital Universitari Vall d'Hebron Research Institute
    ClinicalTrials.gov Identifier:
    NCT03469843
    Other Study ID Numbers:
    • PR(AMI)126/2015
    First Posted:
    Mar 19, 2018
    Last Update Posted:
    Mar 29, 2022
    Last Verified:
    Mar 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Hospital Universitari Vall d'Hebron Research Institute
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 29, 2022